| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc3e5cb7a2da33ea01dae32f31bef542 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
1993-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49a2295eeeab1096e1a4f58ab8796d1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c099428cd858a07a1f51f8c9ef769ce |
| publicationDate |
2001-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0653211-B1 |
| titleOfInvention |
Blood coagulation normalizer containing tcf-ii as active ingredient |
| abstract |
A blood coagulation normalizer containing TCF-II, a glycoprotein produced by human fibroblasts, as the active ingredient. It is efficacious in treating blood coagulation anomaly, such as disseminated intravascular coagulation syndrome, and thrombocytopenia caused by cisplatin administration by promoting the production of blood coagulation factors and increasing the number of thrombocytes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7138372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7306791-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7115568-B2 |
| priorityDate |
1992-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |